Inmune Bio, Inc. (INMB) insider trading.
In Q3 2026, insiders at Inmune Bio, Inc. reported 3 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 3
- Last filed
- 2026-07-07
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Moss David J | Director, Officer · Chief Executive Officer | 1 | 0 | 0 |
| Lowdell Mark William | Officer · Chief Scientific Officer | 1 | 0 | 0 |
| Juda Scott | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-02 | Moss David J | M (A) | 9,014 | $1.4 | 1,294,883 | Form 4 |
| 2026-07-02 | Lowdell Mark William | M (A) | 7,211 | $1.4 | 1,518,017 | Form 4 |
| 2026-07-02 | Juda Scott | M (A) | 14,801 | $1.4 | 86,404 | Form 4 |
Transaction codes in this quarter
Get INMB insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1711754&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · INMB company page · Inmune Bio, Inc. on SEC.gov
Questions
Are insiders buying or selling Inmune Bio, Inc. (INMB)?
In Q3 2026, insiders at Inmune Bio, Inc. reported 3 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Inmune Bio, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/inmb.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.